Organized breast cancer screening has become available throughout France since 2004. According to the French National Cancer Institute, more than 22 million mammograms have been performed during the first ten years of the screening programme, or about 2.45 million mammographies each year. In 2012, the organized screening participation rate was 52.7%, well below the European target of 70%. Solutions must be found to increase this rate to recommended target levels. Three French departments have developed mobile mammography screening programmes, but their participation rates are not higher than the national average and they are associated with a number of obstacles, notably financial and technical. The number of subjects lost to follow-up is 11.4% with mobile screening versus only 2.7% for fixed sites. It is therefore essential to study the many obstacles, including financial and organizational, before setting up this type of mobile mammography programme.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mobile mammography
8
screening
5
[is “mobile
4
“mobile mammography”
4
mammography” relevant
4
relevant method
4
method france?]
4
france?] organized
4
organized breast
4
breast cancer
4

Similar Publications

This article addresses the persistent disparities in breast cancer outcomes across different racial, ethnic, and socioeconomic groups despite advancements in diagnosis and treatment. The disparities are rooted in various factors, including access to care, socioeconomic status, and cultural barriers. The article emphasizes the need for targeted interventions, such as expanding insurance coverage, mobile mammography units, and culturally tailored outreach programs to promote health equity.

View Article and Find Full Text PDF

The intricate terrain of breast cancer (BC) in India is examined in this review, which also looks at screening techniques, geographical differences, epidemiological trends, and obstacles to early diagnosis. BC has a major impact in India, especially on women. The research examines data from 2014 to 2024 and finds that, although overall cancer rates are declining, there has been a noticeable increase in BC cases.

View Article and Find Full Text PDF

Isolated plasmacytoma of the breast: A rare case report.

Int J Surg Case Rep

December 2024

Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. Electronic address:

Introduction And Importance: Solitary plasmacytoma of the breast is an extremely rare manifestation of plasma cell neoplasms, predominantly seen in the bone marrow and commonly associated with multiple myeloma. When it occurs as an isolated lesion in the breast, it presents unique diagnostic and therapeutic challenges due to its rarity and clinical similarity to other breast conditions.

Case Presentation: We report a case of a 60-year-old female presenting with a gradually enlarging mass in her right breast over six months.

View Article and Find Full Text PDF

Early detection through screening could improve breast cancer (BC) outcomes in sub-Saharan Africa (SSA). We explored women's preferences for BC-related mobile health text messaging, described the development of a mobile-health text messaging platform, and examined the enablers and barriers to BC screening. A concurrent mixed-method study of women aged 40-59 years was conducted.

View Article and Find Full Text PDF

Mammary myofibroblastoma (MFB) is a rare benign spindle cell tumour predominantly affecting males, but also observed in postmenopausal females. Its diagnosis remains challenging owing to overlapping histological features with malignant lesions and limited tissue sampling in core biopsies. We present a case of incidentally discovered mammary MFB in a 63-year-old man and review its clinical, radiological and histopathological characteristics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!